# Safety Study of X-82 in Patients With Advanced Solid Tumors

> **NCT01296581** · PHASE1 · COMPLETED · sponsor: **Tyrogenex** · enrollment: 52 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** X-82

## Key facts

- **NCT ID:** NCT01296581
- **Lead sponsor:** Tyrogenex
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2014-01
- **Final completion:** 2017-01
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2022-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01296581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01296581, "Safety Study of X-82 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01296581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*